gadolinium has been researched along with Hemoglobinopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cianciulli, P; D'Ascola, D; Favilli, B; Filosa, A; Lombardi, M; Meloni, A; Pepe, A; Positano, V; Quarta, A; Restaino, G | 1 |
1 trial(s) available for gadolinium and Hemoglobinopathies
| Article | Year |
|---|---|
Safety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies.
Topics: Adolescent; Adult; Child; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Hemoglobinopathies; Humans; Kidney Diseases; Male; Young Adult | 2009 |